BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38115646)

  • 1. Risk of malignancy in incidental oropharyngeal lesions exhibiting fluorodeoxyglucose uptake which proceed to tissue biopsy.
    Key S; Chia C; Magarey M; Dixon B
    ANZ J Surg; 2024 Feb; 94(1-2):122-127. PubMed ID: 38115646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidental uptake of fluorodeoxyglucose in the Waldeyer's ring and risk of oropharyngeal malignancy.
    Bujoreanu I; Gujral D; Wallitt K; Awad Z
    Eur Arch Otorhinolaryngol; 2022 May; 279(5):2657-2664. PubMed ID: 34570264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of incidental [18 F]FDG uptake in the gastrointestinal tract on PET/CT imaging: a retrospective cohort study.
    Shmidt E; Nehra V; Lowe V; Oxentenko AS
    BMC Gastroenterol; 2016 Oct; 16(1):125. PubMed ID: 27716085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidental focal FDG uptake in the parotid glands on PET/CT in patients with head and neck malignancy.
    Seo YL; Yoon DY; Baek S; Lim KJ; Yun EJ; Cho YK; Bae WJ; Chung EJ; Kwon KH
    Eur Radiol; 2015 Jan; 25(1):171-7. PubMed ID: 25182627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidental findings on 18-FDG PET-CT in head and neck cancer. A retrospective case-control study of incidental findings on 18-FDG PET-CT in patients with head and neck cancer.
    Casselden E; Sheerin F; Winter SC
    Eur Arch Otorhinolaryngol; 2019 Jan; 276(1):243-247. PubMed ID: 30535976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and malignancy rate of incidental focal salivary gland lesions identified by 18F-fluorodeoxyglucose-positron emission tomography.
    Danstrup CS; Lyhne NM; Kovacsne A; Fisker R; Zacho HD
    Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):357-364. PubMed ID: 35939059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidental FDG-Avid Focuses in Palatine Tonsils on PET/CT.
    Reinholdt KB; Dias AH; Hoff CM; Gormsen LC; Klug TE
    Laryngoscope; 2022 Dec; 132(12):2370-2378. PubMed ID: 35226376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should We Routinely Investigate Incidental Head and Neck Findings on 18-Fluorodeoxyglucose Positron Emission Tomography in Patients Being Staged for Non-small Cell Lung Cancer? A Retrospective Analysis.
    Patel A; Perry T; Hunt I; Abele J; Maquire C; Allegretto M; Bedard E
    Thorac Cardiovasc Surg; 2015 Oct; 63(7):604-8. PubMed ID: 24959935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical value of incidental 18F-fluorodeoxyglucose-avid foci detected on positron emission tomography/computed tomography.
    Ozkol V; Alper E; Aydin N; Ozkol HF; Topal NB; Akpinar AT
    Nucl Med Commun; 2010 Feb; 31(2):128-36. PubMed ID: 19858768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palatine tonsil SUVmax on FDG PET-CT as a discriminator between benign and malignant tonsils in patients with and without head and neck squamous cell carcinoma of unknown primary.
    Pencharz D; Dunn J; Connor S; Siddiqui A; Sriskandan N; Thavaraj S; Jeannon JP; Oakley R; Lei M; Guerrero-Urbano T; Cook GJ; Szyszko TA
    Clin Radiol; 2019 Feb; 74(2):165.e17-165.e23. PubMed ID: 30454841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The frequency and malignancy rate of incidental focal breast lesions identified by 18F-fluorodeoxyglucose positron emission tomography.
    Andersen JD; Zacho HD; Petersen LJ
    Nucl Med Commun; 2021 Jan; 42(1):93-100. PubMed ID: 33044407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Colonoscopic Results of Patients with Incidental Colonic FDG Uptake in PET/CT Imaging.
    Esmer AC; Öksüzoğlu K; Şen F; Yazıcı H; Tazeoğlu D; Ergelen R; Öneş T; Yeğen ŞC
    World J Surg; 2023 Oct; 47(10):2532-2541. PubMed ID: 37516690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidental colonic focal FDG uptake on PET/CT: can the maximum standardized uptake value (SUVmax) guide us in the timing of colonoscopy?
    van Hoeij FB; Keijsers RG; Loffeld BC; Dun G; Stadhouders PH; Weusten BL
    Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):66-71. PubMed ID: 25139518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is integrated 18F-FDG PET/MRI superior to 18F-FDG PET/CT in the differentiation of incidental tracer uptake in the head and neck area?
    Schaarschmidt BM; Gomez B; Buchbender C; Grueneisen J; Nensa F; Sawicki LM; Ruhlmann V; Wetter A; Antoch G; Heusch P
    Diagn Interv Radiol; 2017; 23(2):127-132. PubMed ID: 28089955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should we worry about incidental gastrointestinal tract involvement in positron emission tomography/computed tomography as gastroenterologist?
    Iliaz R; Cavus B; Yegen G; Alcin G; Gulluoglu M; Karaca C; Demir K; Besısık F; Kaymakoglu S; Turkmen C; Akyuz F
    Acta Gastroenterol Belg; 2018; 81(4):471-475. PubMed ID: 30645914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidental Findings on FDG PET/CT in Head and Neck Cancer.
    Britt CJ; Maas AM; Kennedy TA; Hartig GK
    Otolaryngol Head Neck Surg; 2018 Mar; 158(3):484-488. PubMed ID: 29160180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidental PET/CT findings in the cancer patient: how should they be managed?
    Beatty JS; Williams HT; Aldridge BA; Hughes MP; Vasudeva VS; Gucwa AL; David GS; Lind DS; Kruse EJ; McLoughlin JM
    Surgery; 2009 Aug; 146(2):274-81. PubMed ID: 19628085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast incidentalomas on 18-Fluorodeoxyglucose positron emission tomography-computed tomography performed for a non-mammary cause: Significance and outcomes.
    Menon P; Bourke A
    J Med Imaging Radiat Oncol; 2023 Jun; 67(4):357-364. PubMed ID: 36468633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of 18-Fludeoxyglucose positron emission tomography-computed tomography and subsequent panendoscopy in head and neck squamous cell carcinoma of unknown primary.
    Mani N; George MM; Nash L; Anwar B; Homer JJ
    Laryngoscope; 2016 Jun; 126(6):1354-8. PubMed ID: 26671043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 89Zr-panitumumab Combined With 18F-FDG PET Improves Detection and Staging of Head and Neck Squamous Cell Carcinoma.
    Lee YJ; van den Berg NS; Duan H; Azevedo EC; Ferri V; Hom M; Raymundo RC; Valencia A; Castillo J; Shen B; Zhou Q; Freeman L; Koran ME; Kaplan MJ; Colevas AD; Baik FM; Chin FT; Martin BA; Iagaru A; Rosenthal EL
    Clin Cancer Res; 2022 Oct; 28(20):4425-4434. PubMed ID: 35929985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.